Q1 FY27 results approved; board okays 1.78 MW rooftop solar project

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹112.60

prior close

₹113.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-2.3% vs market

Pharmaceuticals peers, median of 165sector-0.1%-2.3% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3-0.1-2.3-0.1-2.3

Next day

-1.4-0.2-1.2+0.0-1.5

-2.3+0.1-2.5-0.0-2.3

-2.8+0.3-3.1+0.3-3.1

+1.0+0.4+0.6-0.6+1.6

-2.3+0.5-2.8-1.1-1.2

-1.4+0.3-1.7-2.0+0.6

15d

-0.2+1.9-2.0+0.2-0.4

-3.2+2.2-5.4+1.7-4.9

+0.1-1.2+1.3-2.0+2.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited standalone and consolidated results for Q1 FY27 (quarter ended June 30, 2026). Auditor Srinaga and Giridharan issued a clean limited review report with no qualifications. Board also delegated authority to the MD and Executive Director for incorporating subsidiaries, and approved a 1.782 MW grid-connected rooftop solar PV project under the RESCO/OPEX model as a diversification into renewable energy.

Likely market impact

Solar push signals entry into renewable energy; clean audit and subsidiary delegation point to active expansion plans.